Literature DB >> 27824689

Eccentric Cycling: A Promising Modality for Patients with Chronic Heart Failure.

Lauren C Chasland1, Daniel J Green, Andrew J Maiorana, Kazunori Nosaka, Andrew Haynes, Lawrence G Dembo, Louise H Naylor.   

Abstract

PURPOSE: Chronic heart failure (CHF) is characterized by dyspnea and poor exercise tolerance, which decreases aerobic capacity (V˙O2peak), a measure strongly correlated with quality of life and mortality. In healthy populations, eccentric (ECC) cycling can be performed at a lower oxygen demand for matched workload, compared with concentric (CON) cycling, but few studies have previously investigated ECC cycling in CHF. We hypothesized that, when matched for external workload (W), an ECC cycling bout would be performed at a lower cardiorespiratory load (V˙O2) than CON in patients with CHF.
METHODS: Eleven CHF patients (10 males) with impaired left ventricular systolic function (ejection fraction 31% ± 12%) completed a CON V˙O2peak test, with the subsequent ECC and CON protocols set at 70% of individual maximal CON power (W). Oxygen consumption (V˙O2), RER, minute ventilation (V˙E), HR, and rate pressure product were compared between conditions.
RESULTS: ECC was performed at a lower V˙O2 (12.3 ± 1.3 vs 14.1 ± 0.8 mL·kg·min, P = 0.01), RER (0.92 ± 0.02 vs 0.96 ± 0.01, P = 0.01), and V˙E (36.5 ± 4.4 vs 40.2 ± 2.0 L·min, P = 0.04) in comparison with CON, despite both conditions being performed at matched workloads. HR (101 ± 5 vs 96 ± 1 bpm, P = 0.06) and rate pressure product (13,539 ± 788 vs 11,911 ± 227 bpm·mm Hg, P = 0.15) were not significantly different between conditions.
CONCLUSION: When matched for external workload, ECC cycling can be performed with a lower oxygen demand than CON in patients with CHF. Eccentric cycling is a promising modality for cardiac rehabilitation in severely deconditioned patients with CHF.

Entities:  

Mesh:

Year:  2017        PMID: 27824689     DOI: 10.1249/MSS.0000000000001151

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  6 in total

1.  Neuromuscular and Perceptual Responses to Sub-Maximal Eccentric Cycling.

Authors:  Pierre Clos; Davy Laroche; Paul J Stapley; Romuald Lepers
Journal:  Front Physiol       Date:  2019-03-28       Impact factor: 4.566

2.  Effectiveness of combined eccentric and concentric exercise over traditional cardiac exercise rehabilitation programme in patients with chronic heart failure: protocol for a randomised controlled study.

Authors:  Guillaume Plaquevent-Hostache; Julianne Touron; Frédéric Costes; Hélène Perrault; Guillaume Clerfond; Christine Cuenin; Andreea Moisa; Bruno Pereira; Marie-Claire Boiteux; Romain Eschalier; Ruddy Richard
Journal:  BMJ Open       Date:  2019-09-26       Impact factor: 2.692

3.  Global Corticospinal Excitability as Assessed in A Non-Exercised Upper Limb Muscle Compared Between Concentric and Eccentric Modes of Leg Cycling.

Authors:  Joel A Walsh; Paul J Stapley; Jonathan B H Shemmell; Romuald Lepers; Darryl J McAndrew
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

4.  The time course of different neuromuscular adaptations to short-term downhill running training and their specific relationships with strength gains.

Authors:  Robert M Erskine; Fabrice Vercruyssen; Bastien Bontemps; Mathieu Gruet; Julien Louis; Daniel J Owens; Stella Miríc
Journal:  Eur J Appl Physiol       Date:  2022-02-18       Impact factor: 3.078

5.  A Semi-recumbent Eccentric Cycle Ergometer Instrumented to Isolate Lower Limb Muscle Contractions to the Appropriate Phase of the Pedal Cycle.

Authors:  Joel A Walsh; Darryl J McAndrew; Douglas J Henness; Jonathan Shemmell; Dominic Cuicuri; Paul J Stapley
Journal:  Front Physiol       Date:  2021-11-29       Impact factor: 4.566

6.  Leg Muscle Activity and Perception of Effort before and after Four Short Sessions of Submaximal Eccentric Cycling.

Authors:  Pierre Clos; Romuald Lepers
Journal:  Int J Environ Res Public Health       Date:  2020-10-22       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.